NorthWest Biotherapeutics Inc (NWBO)

[Troymister]

These first two sentences from a story in today's NY Times reflect how lack of broad scientific confirmation detracts from a study's credibility:

"In a small clinical trial, an experimental Alzheimer’s drug slowed the rate at which patients lost the ability to think and care for themselves, the drug maker Eli Lilly announced on Monday. The findings have not been published in any form, and not been widely reviewed by other researchers."